Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection; VGX-6150-01

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitlePhase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection; VGX-6150-01
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsSangHoon Ahn